Clinical trial Recruiting at 7 sites Observational Ages 18 and up

Collecting blood and stool samples to detect colorectal cancer in Lynch syndrome patients

Official title: Detection of Colorectal Cancer or Advanced Neoplasia by Stool DNA in Lynch Syndrome: CORAL Study

Run by Mayo Clinic · NCT05410977 · Data updated 2026-11-12

This study is testing a new stool DNA test to see if it can help find colorectal cancer in people with Lynch syndrome by collecting their blood and stool samples.

More Colorectal Carcinoma trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment950 (estimated)
SponsorMayo Clinic
Academic / other
Drugs / interventionschemotherapy, radiation
Locations9 sites (Scottsdale, Arizona and 8 other locations)
StatusRecruiting
StartedMarch 30, 2022
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedAugust 18, 2026
Trial IDNCT05410977 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults diagnosed with Lynch syndrome or those with early onset colorectal cancer under the age of 50.

Probably not a fit

Patients with known cancer stages I-IV or those who have received certain cancer treatments in the past five years may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the effectiveness of a multitarget stool DNA test for detecting colorectal neoplasia in patients with Lynch syndrome. Participants will provide blood and stool samples, which will be collected within a specific timeframe around their scheduled colonoscopy or flexible sigmoidoscopy. The study also seeks to create a biorepository of these samples for future research. Medical records of the participants will be reviewed to gather additional data.

Why it matters

Potential benefit: If successful, this study could lead to improved early detection of colorectal cancer in patients with Lynch syndrome, potentially saving lives.

How similar studies have gone: Other studies have shown promise in using DNA screening techniques for cancer detection, suggesting that this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients at least 18 years of age
* Individuals diagnosed with Lynch syndrome (mutation in MLH1, MSH2, MSH6, PMS2, EPCAM) or colorectal cancer (CRC) with suspected Lynch syndrome or individuals diagnosed with early onset CRC (\<55 years old)
* Colonoscopy/flexible sigmoidoscopy (flex sig) scheduled +/- 90 days from sample collection
* Patient has agreed to participate and has signed the study consent form

Exclusion Criteria:

* Patient has known cancer (stage I-IV) within 5 years prior to current sample collection (not including basal cell or squamous cell skin cancers; if patient has not been seen or if information is not available, the patient is eligible)
* Patient has received chemotherapy class drugs for the treatment of cancer in the 5 years prior to current sample collection
* Patient has had any abdominal radiation therapy prior to current sample collection
* Patient had therapy to the target (non-hyperplastic) lesion with intent to completely remove or debulk the lesion prior to sample collection \[examples include snare polypectomy, endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), surgical resection, trans anal excision\]
* Patient has prior diagnosis of non-lynch hereditary colon cancer syndrome \[familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), Peutz-Jeghers syndrome (PJS), juvenile polyposis syndrome (JPS), PTEN, POL\]
* ADDITIONAL STOOL EXCLUSIONS:
* Bowel prep \<7 days prior to stool collection
* Oral or rectal contrast given within 7 days prior to stool collection
* Presence of ileostomy
* Enteral feeds or total parenteral nutrition (TPN)
* Diagnosis of inflammatory bowel disease

Where it's running

  • Mayo Clinic in Arizona
    Scottsdale, Arizona, United States
    Recruiting
  • University of Colorado Anschutz Medical Center
    Aurora, Colorado, United States
    Recruiting
  • Mayo Clinic in Florida
    Jacksonville, Florida, United States
    Recruiting
  • Dana Farber Cancer Institute
    Boston, Massachusetts, United States
    Recruiting
  • Mayo Clinic
    Rochester, Minnesota, United States
    Recruiting
  • University of Pennsylvania
    Philadelphia, Pennsylvania, United States
    Recruiting
Show 3 more locations
  • University of Washington
    Seattle, Washington, United States
    Recruiting
  • University of California San Francisco
    San Francisco, California, United States
    Completed
  • Beth Israel Deaconess Medical Center
    Boston, Massachusetts, United States
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.